Alpha-linolenic Acid and the Risk of ASCVD

Completed

Phase N/A Results N/A

Summary of Purpose

Background: The plant-derived omega-3 fatty acid alpha-linolenic acid (ALA, 18:3-n-3) may reduce the risk of atherosclerotic cardiovascular disease, including incident myocardial infarction, ischemic stroke and peripheral artery disease. However, the results of previous studies have been inconsistent. Objectives: To investigate the associations between dietary intake of ALA, adipose tissue content of ALA,...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 August 2017.

24 Nov 1993 19 Aug 2017 10 Jul 2013 10 Jul 2013 1 Aug 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts

Not available